Overview
Acromelic frontonasal dysplasia (AFND) is an extremely rare congenital malformation syndrome characterized by the combination of frontonasal dysplasia (abnormal development of the front of the face and nose) and limb anomalies, particularly affecting the hands and feet (acromelic involvement). The condition is present at birth and affects multiple body systems, most prominently the craniofacial structures and the skeletal system. Key craniofacial features include widely spaced eyes (hypertelorism), a broad or bifid nasal tip, median cleft of the nose or upper lip, and sometimes central nervous system anomalies such as agenesis of the corpus callosum or encephalocele. Limb abnormalities typically include preaxial polydactyly (extra digits on the thumb or big toe side), brachydactyly (short fingers or toes), and tibial hypoplasia or aplasia. At least two genetic subtypes have been described. Acromelic frontonasal dysplasia type 1 (AFND1) is caused by pathogenic variants in the ZSWIM6 gene, while type 2 (AFND2) has been linked to variants in the NBAS gene. Both forms follow an autosomal recessive inheritance pattern. Intellectual disability of variable severity may be present in some affected individuals. Additional features can include cryptorchidism, brain malformations, and talipes equinovarus (clubfoot). There is currently no cure or disease-specific treatment for acromelic frontonasal dysplasia. Management is supportive and symptomatic, typically involving a multidisciplinary team including craniofacial surgeons, orthopedic specialists, neurologists, and developmental specialists. Surgical correction of craniofacial and limb anomalies may be undertaken depending on severity. Early developmental intervention and educational support are recommended for individuals with intellectual disability. Genetic counseling is important for affected families to understand recurrence risks.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
1 eventZhejiang Cancer Hospital — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Acromelic frontonasal dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Acromelic frontonasal dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Acromelic frontonasal dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Acromelic frontonasal dysplasia.
Community
No community posts yet. Be the first to share your experience with Acromelic frontonasal dysplasia.
Start the conversation →Latest news about Acromelic frontonasal dysplasia
Disease timeline:
New recruiting trial: Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery
A new clinical trial is recruiting patients for Acromelic frontonasal dysplasia
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Acromelic frontonasal dysplasia
What is Acromelic frontonasal dysplasia?
Acromelic frontonasal dysplasia (AFND) is an extremely rare congenital malformation syndrome characterized by the combination of frontonasal dysplasia (abnormal development of the front of the face and nose) and limb anomalies, particularly affecting the hands and feet (acromelic involvement). The condition is present at birth and affects multiple body systems, most prominently the craniofacial structures and the skeletal system. Key craniofacial features include widely spaced eyes (hypertelorism), a broad or bifid nasal tip, median cleft of the nose or upper lip, and sometimes central nervous
How is Acromelic frontonasal dysplasia inherited?
Acromelic frontonasal dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Acromelic frontonasal dysplasia typically begin?
Typical onset of Acromelic frontonasal dysplasia is neonatal. Age of onset can vary across affected individuals.